NEW ENTERPRISE ASSOCIATES 13 LP's Net Worth

$1.67 Billion

Estimate Recalculated Feb 16, 2024 05:38PM EST

Who is NEW ENTERPRISE ASSOCIATES 13 LP?

NEW ENTERPRISE ASSOCIATES 13 LP has an estimated net worth of $1.67 Billion. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, BuzzFeed, Inc., Sprout Social, Inc., Clovis Oncology, Inc., BOX INC, Coursera, Inc., Dermira, Inc., PhaseBio Pharmaceuticals Inc, GLYCOMIMETICS INC, Epizyme, Inc., MINERVA SURGICAL INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., and CVENT INC.

SEC CIK

NEW ENTERPRISE ASSOCIATES 13 LP's CIK is 0001452907

Past Insider Trading and Trends

2014 was NEW ENTERPRISE ASSOCIATES 13 LP's most active year for acquiring shares with 16 total transactions. NEW ENTERPRISE ASSOCIATES 13 LP's most active month to acquire stocks was the month of September. 2014 was NEW ENTERPRISE ASSOCIATES 13 LP's most active year for disposing of shares, totalling 21 transactions. NEW ENTERPRISE ASSOCIATES 13 LP's most active month to dispose stocks was the month of September. 2016 saw NEW ENTERPRISE ASSOCIATES 13 LP paying a total of $39,405,647.57 for 11,034,334 shares, this is the most they've acquired in one year. In 2019 NEW ENTERPRISE ASSOCIATES 13 LP cashed out on 65,229,034 shares for a total of $726,077,850.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cloudflare, Inc. (NET) Snapshot price: $83.32

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
2.76M
Nov 11
Form 4
-31.92%
-1.30M
2.76M
Aug 7
Form 4
0
4.06M
May 19
Form 4
4.06M
4.06M
Sep 17
Form 3
0
0
No matching records found

Sagimet Biosciences Inc. (SGMT) Snapshot price: $6.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.08%
-850.00K
3M
Jan 29
Form 4
+10,119.44%
3.81M
$13.65
-$10,592.00
3.85M
Jul 18
Form 3
0
0
No matching records found

Sprout Social, Inc. (SPT) Snapshot price: $61.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-44.78%
-2.50M
3.08M
Nov 13
Form 4
-38.14%
-3.44M
$27.50
-$94,650,765.00
5.58M
Aug 17
Form 4
9.02M
9.02M
Dec 17
Form 3
0
0
No matching records found

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-26.86%
-1.78M
$0.15
-$262,264.02
4.86M
Oct 25
Form 4
6.64M
$5.00
6.64M
Oct 22
Form 3
0
0
No matching records found

GLYCOMIMETICS INC (GLYC) Snapshot price: $3.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.09M
$8.00
4.09M
Jan 15
Form 3
0
0
No matching records found